Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)

Abroad (travel likely)RecruitingPHASE1

Conditions

HIV-1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Infectious Diseases, Q Research, Aarhus, Denmark
Contact: Study coordinator (Thomas A Rasmussen, Associate Professor, MD, PhD) · thomrasm@rm.dk · +4593801394
Contact: Study coordinator (Jesper D Gunst, MD, PhD) · jesdam@rm.dk · +4523886636
Hospital Universitari Germans Trias I Pujol, Department of Infectious Diseases, Badalona, Spain
Contact: Study coordinator (José M Marhuenda, MD, PhD) · jmolto@lluita.org · +34934657897

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART

HIV-1-infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Aarhus, Denmark

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

HIV-1-infection

Abroad (travel likely)RecruitingEARLY_PHASE1

San Diego, United States

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

HIV Infected Individuals · HIV

Abroad (travel likely)RecruitingPHASE1

Tianjin, China

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

HIV

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States